Outsourcing STREAM

  1. Multi-Site Capabilities For Your Phase I-II Trials 5/1/2026

    Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.

  2. Outsourcing Clinical Trial Disclosure Management 6/3/2020

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

  3. See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada 3/23/2023

    Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.

  4. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

  5. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

    Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

  6. We Are Altasciences: Proactive Drug Development 1/30/2023

    When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.

  7. Streamlining Patient Access To Cell And Gene Therapies 12/21/2023

    Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.

  8. Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments 5/5/2023

    Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.

  9. The Heart Of The Matter: Early Vs. Late QT Prolongation Testing 2/8/2023

    Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

  10. A Different Kind Of CRO 1/30/2023

    Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.